ECG Analysis for Arrhythmia Risk Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying the risk of sudden cardiac death due to arrhythmia are inadequate, as they fail to accurately predict individuals who would benefit from implantable cardioverter defibrillators or anti-arrhythmic therapeutics.
Innovation Solution
The method involves analyzing the change in relationship between action potential duration and diastolic interval over multiple time periods in ECG leads, using a Regional Restitution Instability Index (R2I2) and Peak Electrocardiogram Restitution Gradient (PERG) to assess cardiac function and predict arrhythmia risk.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional ECG assessment methods (QT dispersion) are used to identify arrhythmia risk, then the assessment is non-invasive and easy to perform, but the measurement precision and reliability are insufficient
Solution Approach 1:
The patent transforms the traditional ECG analysis parameters (QT interval, QT dispersion) into a new parameter (APD restitution gradient) that directly reflects arrhythmia risk. This parameter change enables more accurate prediction of sudden cardiac death by analyzing the relationship between action potential duration and diastolic interval across multiple heart rates, rather than relying on static interval measurements.
Solution Approach 2:
The patent introduces dynamic assessment by measuring APD restitution at multiple heart rates (different diastolic intervals) rather than at a single fixed rate. This dynamic approach captures the heart's electrical behavior under varying conditions, improving the reliability of arrhythmia risk stratification while maintaining the non-invasive nature of ECG.
2Measurement precision
If intra-cardiac electrodes are used for direct cardiac tissue measurement, then measurement precision improves, but the invasiveness and ease of operation deteriorate
Solution Approach 1:
The patent creates a surface ECG-based copy of the intra-cardiac electrical measurements by analyzing APD restitution from external ECG leads. This copying approach replicates the information obtained from invasive electrodes using non-invasive surface measurements, maintaining measurement precision while eliminating the need for direct cardiac tissue contact.
Solution Approach 2:
The patent replaces the mechanical/invasive approach of inserting electrodes into cardiac tissue with a non-invasive electrical field-based method. By analyzing the electrical potential differences on the skin surface through sophisticated APD restitution analysis, the system substitutes physical intrusion with field-based measurement.
3Reliability
If standard NICE guidelines screening is used for sudden cardiac death risk, then the screening is simple and widely applicable, but the reliability of identifying high-risk individuals is insufficient
Solution Approach 1:
The patent incorporates feedback by analyzing how APD changes in response to varying diastolic intervals (heart rates). This feedback mechanism reveals the heart's electrical adaptability and identifies abnormal restitution patterns that predict arrhythmia risk, improving the reliability of risk identification beyond static guideline criteria.
Solution Approach 2:
The patent performs preliminary risk assessment through APD restitution analysis before clinical decisions are made. By identifying individuals with abnormal restitution gradients early, the method enables proactive intervention and more accurate stratification of patients who would benefit from implantable defibrillators or anti-arrhythmic therapy.
Data Source
Figure 1A
Figure 1B
Figure 2A
AI summary
A method for assessing the electrical function of a heart, a method for determining a subject's need for the implantation of an implantable cardioverter defibrillator or the need for administration of an anti-arrhythmic agent, and apparatus for assessing the function of the heart and a computer program product. The methods and products involve analysis of ECG.